PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Public Health, Institute of Health and Biological Studies, Universidade Federal do Sul e Sudeste do Pará, Marabá, Pará, Brazil.\', \'Researcher of the Group (Cnpq) for Epidemiological, Economic and Pharmacological Studies of Arboviruses (EEPIFARBO) - Universidade Federal Do Sul E Sudeste Do Pará; Avenida Dos Ipês, Marabá, Pará, Brazil.\', \'SUS Collaborating Centre for Technology Assessment and Excellence in Health, Sala 1042, Faculdade De Farmácia, Universidade Federal De Minas Gerais, Av. Presidente Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, Brazil.\', \'Department of Statistics, Exact Sciences Institute, Universidade Federal De Minas Gerais, Belo Horizonte, Brazil.\', \'Programa De Pós-Graduação Em Medicamentos E Assistência Farmacêutica, School of Pharmacy, Universidade Federal De Minas Gerais, Belo Horizonte, Brazil.\', \'Department of Pharmacoepidemiology, Institute of Pharmacy and Biomedical Sciences, Glasgow, UK.\', \'Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.\', \'Health Economics Centre, Liverpool University Management School, Liverpool, UK.\', \'School of Pharmacy, Department of Public Health and Pharmacy Management, Sefako Health Sciences University, Pretoria, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/14737167.2021.1931128
?:hasPublicationType
?:journal
  • Expert review of pharmacoeconomics & outcomes research
is ?:pmid of
?:pmid
?:pmid
  • 33993823
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all